Executive Director, Clinical Development

The Company is seeking an Executive Director of Clinical Development to lead clinical strategy for trials in rare kidney diseases. The role includes shaping development plans and study designs, overseeing trial conduct, interpreting clinical data, and contributing to indication strategy and lifecycle planning. The executive will lead cross-functional program teams, align goals and milestones, identify risks, and present recommendations to governance groups. Responsibilities also include contributing to regulatory strategy and health authority interactions, building relationships with external experts and patient groups, and supporting assessment of potential development opportunities. Candidates must hold an MD, DO, or equivalent medical degree; advanced nephrology training is strongly preferred. At least 10 years of relevant clinical research or drug development experience is required, including five or more years in a leadership role guiding development strategy and major program decisions. Experience in nephrology, rare disease, clinical trial design, regulatory submissions, and health authority interactions is highly valued. Strong scientific data interpretation, communication, collaboration, and organizational skills are essential, along with an understanding of rare disease development challenges; experience with global trials, renal biomarkers, or pediatric development is an advantage.